GoodRx Holdings Files 2025 Proxy Statement
Ticker: GDRX · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1809519
| Field | Detail |
|---|---|
| Company | Goodrx Holdings, Inc. (GDRX) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: GDRX
TL;DR
GoodRx proxy statement out, exec comp details for Wagner, Hirsch, Bezdek for FY24.
AI Summary
GoodRx Holdings, Inc. filed its DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key individuals mentioned in relation to compensation for 2024 include Wagner, Hirsch, and Bezdek.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and corporate governance, enabling informed voting decisions on company leadership and strategy.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) detailing executive compensation and corporate governance, not indicating new or immediate risks.
Key Players & Entities
- GoodRx Holdings, Inc. (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end
- 2025-04-23 (date) — Filing date
- Wagner (person) — Executive compensation recipient
- Hirsch (person) — Executive compensation recipient
- Bezdek (person) — Executive compensation recipient
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit shareholder proxies for its annual meeting, providing detailed information on matters to be voted upon, including executive compensation, director elections, and other corporate governance issues.
Which fiscal year does this DEF 14A filing primarily cover?
This DEF 14A filing covers the fiscal year ending December 31, 2024.
Who are some of the individuals mentioned in relation to executive compensation for the covered fiscal year?
Individuals mentioned in relation to executive compensation for the covered fiscal year include Wagner, Hirsch, and Bezdek.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 23, 2025.
What is the company's principal business address as listed in the filing?
The company's principal business address is 2701 Olympic Boulevard, Santa Monica, CA 90404.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 by Wagner regarding GoodRx Holdings, Inc. (GDRX).